NSAIDs

 Composition: Nepafenac 0.1% w/v, Benzalkonium Chloride solution IP 0.1%

Indications:

• Inflammation of Anterior $ Posterior segment,
• Drug of choice for CME, Retinitis,
• Post surgical pain, IOL implantation,
• Phacoemulsification

Description:

• Reduces the risk of postoperative Macular Edema.
• Improvement in BCVA outcomes following Cataract Surgery in patients with nonproliferative diabetic retinopathy.
• Enhanced permeability compared with other Non Steroidal Anti-Inflammatopry Drugs.

Presentation- 5 ml

Dosage Form: Eye Drop

How to Use: As directed by physician

Composition: Bromfenac 0.09 % W/V

Indications:

• Management of Post-Lasik pain and inflammation
• Treatment of CME anterior uveitis
• Intra-operative miosis.

Description:

• Possess greater half life therefore needs only ‘Twice Daily’ application.
• Superior to Ketorolac in reducing post-operative pain following LASIK or EPI-LASIK.

Presentation: 5 ml

Dosage Form: Eye Drop

How to Use: As directed by physician

Composition: Flurbiprofen Sodium 0.03% w/v + HPMC (Hydroxy Propyl Methyl Cellulose) 0.25% W/V

Indications:

• Inhibition of Intra-operative miosis
• Inflammation after cataract or Glaucoma Laser Surgery

Description:

• Effective in preventing miosis during cataract surgery.
• Approved by the USFDA for intraoperative use during cataract surgery to control miosis.

Presentation: 5 ml

Dosage Form: Eye Drop

How to Use: As directed by physician